UBS O'Connor’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $590K | Sell |
100,317
-47,378
| -32% | -$279K | 0.03% | 241 |
|
|
2025
Q1 | $1.24M | Sell |
147,695
-126,505
| -46% | -$1.06M | 0.04% | 154 |
|
|
2024
Q4 | $2.04M | Buy |
274,200
+56,445
| +26% | +$420K | 0.05% | 151 |
|
|
2024
Q3 | $1.26M | Buy |
217,755
+4,779
| +2% | +$27.7K | 0.03% | 245 |
|
|
2024
Q2 | $1.42M | Buy |
212,976
+77,063
| +57% | +$512K | 0.04% | 243 |
|
|
2024
Q1 | $1.77M | Sell |
135,913
-19,000
| -12% | -$248K | 0.05% | 192 |
|
|
2023
Q4 | $1.98M | Sell |
154,913
-18,091
| -10% | -$231K | 0.06% | 172 |
|
|
2023
Q3 | $2.27M | Buy |
173,004
+60,551
| +54% | +$794K | 0.04% | 223 |
|
|
2023
Q2 | $2.88M | Sell |
112,453
-33,106
| -23% | -$847K | 0.06% | 199 |
|
|
2023
Q1 | $3.67M | Buy |
+145,559
| New | +$3.67M | 0.09% | 182 |
|
|
2022
Q4 | – | Sell |
-132,637
| Closed | -$2.93M | – | 295 |
|
|
2022
Q3 | $2.93M | Sell |
132,637
-6,000
| -4% | -$132K | 0.03% | 438 |
|
|
2022
Q2 | $1.99M | Buy |
+138,637
| New | +$1.99M | 0.02% | 652 |
|